Walleye Trading LLC Xenon Pharmaceuticals Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $42,836 - $49,821	1,254 Added 22.12%	6,923 $236,000
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $81,595 - $101,970	-2,342 Reduced 29.23%	5,669 $218,000
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $268,048 - $323,243	8,011 New	8,011 $286,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $172,516 - $223,111	5,603 New	5,603 $202,000
Q4 2018 Feb 14, 2019	SELL	$5.61 - $12.62 $64,346 - $144,751	-11,470 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $103,230 - $170,903	11,470 New	11,470 $151,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.